CME Group reported earnings this morning and the most striking disconnect is between options traders who have abruptly swung to their most call-heavy posture in months and short sellers who quietly rebuilt positions through the week.
The options signal is the clearest narrative shift since the July 15 note. The put/call ratio has dropped to 0.71, more than 2.5 standard deviations below its 20-day average of 0.90 — making this the most bullish options reading of the past year, near the 52-week low of 0.59. That marks a sharp reversal from a period when the ratio consistently held around 0.95–1.00. Options traders are, in aggregate, tilting toward calls rather than hedges for the first time in a sustained way this cycle. The move is notable given that the prior note flagged uniform target cuts and bearish flow going into today's print.
Short interest tells a less comfortable story. Shorts added roughly 38% to their position over the past month — from around 4.6 million to 6.4 million shares, now running at 1.8% of the free float. That is still a low absolute level, and the borrow market confirms there is no structural squeeze risk: availability is effectively unconstrained, and cost to borrow is a negligible 0.47%, actually down 17% on the week despite the position build. Shorts are adding, but the lending market shows no stress whatsoever.
The Street remains in a holding pattern shaped by those pre-earnings target cuts. Piper Sandler, Morgan Stanley, Barclays, UBS, and TD Cowen all trimmed targets in the two weeks before today's print, while maintaining their ratings. The consensus mean is around $281, roughly 18% above the current price of $237. The bull case rests on the 8.1% revenue growth CME reported this quarter, a 14.5% jump in Market Data, and over 14 years of consecutive dividend increases — a dividend score that ranks in the 91st percentile among peers. The bear case centres on anticipated pressure from interest rate futures if the Fed cuts, competitive encroachment from FMX, and full-year revenue guidance tracking below consensus. The PE has eased to around 18.9x and EV/EBITDA to 16.7x, both drifting lower over the past month as the stock pulled back — a modest valuation reset but not yet at a level that has historically attracted aggressive buying.
The peer group took a broad hit on the day. CBOE fell 1.4%, TW dropped 3.2%, and ICE shed 2.0% — so CME's 3.2% decline was in line with sector pressure rather than a stock-specific reaction. MKTX also fell over 2%. The exchange operator group is moving together, suggesting macro repricing rather than CME-specific disappointment is driving at least part of the daily move.
The next focal point is how analyst targets respond to today's print — whether the firms that held positive ratings and trimmed targets pre-earnings move to restore them, stay put, or cut further will define whether the current gap between price and consensus ($237 vs $281) starts to close or widens.
See the live data behind this article on ORTEX.
Open CME on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
